Product Description
Mycophenolic Acid Delayed Release Tablets USP 360 mg are a best-seller in immunosuppressant therapy, providing world-class efficacy for organ transplant recipients. The cost-effective and customizable formulation employs a delayed-release mechanism, ensuring incomparable targeted intestinal absorption of Mycophenolic Acid for optimal therapeutic effect. Each light yellow, film-coated tablet is USP grade and of inestimable purity, available in convenient 10-tablet blister packs and 30-tablet cartons. For prescription use only, this product should be used under strict medical supervision and is contraindicated in pregnancy. Distributed and exported from India by verified suppliers.
Applications and Utility of Mycophenolic Acid 360 mg Tablets
Beyond its primary indication in preventing organ transplant rejection, Mycophenolic Acid Delayed Release Tablets USP 360 mg may be assessed for other specialized immunosuppressive needs under medical guidance. Its robust profile makes it suitable for critical healthcare settings, especially where targeted immunosuppression is vital. While plant manufacturing details are proprietary, the formulation is developed following stringent pharmaceutical standards, ensuring safety and consistency throughout diverse healthcare applications.
Domestic Availability, Packaging Solutions, and Efficient Delivery
Mycophenolic Acid Delayed Release Tablets USP 360 mg are mainly supplied across Indias major domestic healthcare markets. Every order receives comprehensive packaging details upon quotation, with each carton containing three blister packs of 10 tablets. Relying on an efficient dispatching process, drop-off and delivery are available within routine timelines, ensuring timely access for healthcare providers and patients. Inquire for up-to-date delivery windows and customization options directly from our distribution team.
FAQs of Mycophenolic Acid Delayed Release Tablets USP 360 mg:
Q: How should Mycophenolic Acid Delayed Release Tablets USP 360 mg be used?
A: These tablets should be administered orally, as prescribed by a healthcare professional, usually in combination with other immunosuppressants to prevent organ transplant rejection. Always follow your physicians specific dosage and instructions.
Q: What makes this formulation of Mycophenolic Acid unique?
A: The delayed-release feature ensures targeted intestinal absorption, providing world-class effectiveness and reducing potential gastrointestinal side effects. Its USP-grade quality guarantees incomparable purity and reliability.
Q: When should I avoid taking Mycophenolic Acid 360 mg tablets?
A: These tablets are contraindicated in pregnancy and must only be used under strict medical supervision. Discuss your medical history with your doctor to identify any other conditions that might prevent safe use.
Q: Where can I obtain packaging and order information?
A: Packaging includes 10 tablets per blister pack and 30 tablets per carton. For quotations, order customization, and delivery specifics, contact the distributor or supplier as indicated on the carton packaging.
Q: What is the process for dispatching and delivery of these tablets?
A: Upon confirming your order and issuing a quotation, the dispatching process ensures the product is securely packed and drop-off is organized according to destination and logistics availability within India.